APREA THERAPEUTICS INC (APRE) Stock Cash Flow
USA - NASDAQ:APRE - US03836J2015 - Common Stock
1.5 USD
+0.02 (+1.35%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.85M | -12.96M | -14.29M | -112.66M | -37.13M | |||
| Depreciation Amortization | 20.00K | 20.00K | 10.00K | 0.00 | 10.00K | |||
| Change In Working Capital | 470.00K | -1.06M | 1.62M | -1.76M | -8.33M | |||
| Other non cash items | 620.00K | 440.00K | 480.00K | 89.41M | 7.76M | |||
| OPERATING CASH FLOW | -13.18M | -14.00M | -12.00M | -25.01M | -37.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -20.00K | -90.00K | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | -20.00K | -90.00K | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 460.00K | 16.00M | 5.79M | 680.00K | 1.75M | |||
| Other Financing Activity | -30.00K | -1.32M | -650.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 440.00K | 15.00M | 5.14M | 680.00K | 1.75M | |||
| Exchange Rate Effect | 0.00 | -10.00K | -10.00K | 40.00K | 0.00 | |||
| CHANGE IN CASH | -12.74M | 970.00K | -6.96M | -24.29M | -35.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.18M | -14.00M | -12.00M | -25.01M | -37.69M | |||
| Capital Expenditure | N/A | -20.00K | -90.00K | 0.00 | 0.00 | |||
| FREE CASH FLOW | -13.18M | -14.02M | -12.09M | -25.01M | -37.69M | |||
All data in USD